PATENT CLAIM ANALYSIS

Application Number: 16040640
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["424", "489000"]

Abstract:
The disclosure provides nanoparticles of indirubin and methods of making and using these particles for the treatment of cancer, neurodegenerative disorders and inflammatory diseases. The effective average particle size of the nanoparticles is less than 2000 nm.

Claim (Index 24):
The method of  claim 20 , wherein said contacting comprises:\n (a) dissolving the particles in a solvent to form a first solution; (b) adding the first solution to a second solution comprising at least one surface stabilizer; and (c) precipitating solubilized indirubin or derivatives thereof, and said at least one surface stabilizer.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 95.0
- Lexical Diversity: 1.29032
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14573212', '13110647', '11402264', '11802542', '10784900']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6780766336719888
- 35 USC 102 Novelty (BERT): 0.5489898654083251
- Combined Prediction Score: 0.6651679568456224
- Mean Citation Score: 259.352626
- Max Citation Score: 397.74222
- Similarity Product: 302.32974363530866

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test